10 Undervalued Large Cap Stocks in India 2026

(Updated 3 July 2026)

Investing in undervalued stocks can be a rewarding strategy, especially when focusing on large-cap companies with strong fundamentals. This curated list highlights 10 undervalued large-cap stocks in India for 2026 that are trading below a P/E of 20, offering growth potential and profitability.

How This List Was Generated

>

Summary Table

#	Stock Name (Symbol)	Market Cap (₹ Cr)	P/E	ROE (%)	Rev Growth YoY (%)	Piotroski Score
1	Coal India Limited (COALINDIA)	₹2,65,274.64	8.93	26.11	35.51	6/9
2	NMDC Limited (NMDC)	₹72,128.07	9.00	21.87	34.16	6/9
3	Hindustan Zinc Limited (HINDZINC)	₹2,59,159.94	16.02	61.13	18.62	6/9
4	Hero MotoCorp Limited (HEROMOTOCO)	₹1,14,721.47	17.64	26.57	16.45	5/9
5	Zydus Lifesciences Limited (ZYDUSLIFE)	₹92,794.9	17.39	18.59	16.81	3/9
6	National Aluminium Company Limited (NATIONALUM)	₹66,036.09	12.23	26.83	6.29	5/9
7	Lloyds Metals and Energy Limited (LLOYDSME)	₹65,735.26	18.31	26.54	158.19	4/9
8	Lupin Limited (LUPIN)	₹1,05,279.86	19.81	23.76	23.12	5/9
9	Indus Towers Limited (INDUSTOWER)	₹1,19,832.25	15.43	18.02	7.87	7/9
10	Lodha Developers Limited (LODHA)	₹99,565.1	19.71	14.72	21.02	6/9

Individual Stock Analysis

Coal India Limited (COALINDIA) — ₹2,65,274.64 Cr

Coal India Limited is India’s largest coal producer, operating in the energy sector. With a P/E of 8.93x and a revenue growth of 35.51% YoY, the stock appears undervalued relative to its fundamentals. Its ROE of 26.11% and a dividend yield of 5.84% further strengthen its appeal. However, PAT growth has declined by -12.06% YoY, which investors should monitor.

>

NMDC Limited (NMDC) — ₹72,128.07 Cr

NMDC operates in the basic materials sector, primarily iron ore mining. With a P/E of 9.00x and a robust ROCE of 24.25%, the stock is trading below its intrinsic value. Revenue growth of 34.16% YoY and a dividend yield of 4.59% add to its attractiveness. However, its dependency on commodity prices could pose risks.

>

Hindustan Zinc Limited (HINDZINC) — ₹2,59,159.94 Cr

Hindustan Zinc is a leading producer of zinc and silver. With a stellar ROE of 61.13% and operating profit margin (OPM) of 46.63%, the stock is highly profitable. A P/E of 16.02x and PAT growth of 33.6% YoY make it a strong candidate for value investors. However, its relatively high debt-to-equity ratio of 0.39 warrants caution.

>

Hero MotoCorp Limited (HEROMOTOCO) — ₹1,14,721.47 Cr

Hero MotoCorp, the world’s largest two-wheeler manufacturer, is a key player in the consumer cyclical sector. The stock trades at a P/E of 17.64x with a solid ROE of 26.57%. Revenue growth of 16.45% YoY and a dividend yield of 3.46% make it attractive. However, competition in the auto sector remains a challenge.

>

Zydus Lifesciences Limited (ZYDUSLIFE) — ₹92,794.9 Cr

Zydus Lifesciences operates in the healthcare sector, focusing on pharmaceuticals. The stock’s P/E of 17.39x and ROE of 18.59% suggest it is reasonably valued. Revenue growth of 16.81% YoY is promising, but its Piotroski score of 3/9 indicates weaker financial health compared to peers.

>

National Aluminium Company Limited (NATIONALUM) — ₹66,036.09 Cr

National Aluminium Company is a major player in the basic materials sector. With a P/E of 12.23x and an impressive ROCE of 30.86%, the stock offers strong fundamentals. A dividend yield of 2.85% and steady revenue growth of 6.29% YoY add to its appeal. However, its growth rate lags behind other stocks on this list.

>

Lloyds Metals and Energy Limited (LLOYDSME) — ₹65,735.26 Cr

Lloyds Metals operates in the basic materials sector, focusing on steel and energy. With a P/E of 18.31x and extraordinary revenue growth of 158.19% YoY, the stock has shown explosive growth. However, a high debt-to-equity ratio of 1.49 and negative free cash flow (-₹74,135 Cr) are risks investors should evaluate.

>

Lupin Limited (LUPIN) — ₹1,05,279.86 Cr

Lupin is a global pharmaceutical company with a P/E of 19.81x and a strong ROCE of 26.82%. PAT growth of 62.51% YoY highlights its earnings potential. However, its dividend yield of 0.52% is relatively low, which may deter income-focused investors.

>

Indus Towers Limited (INDUSTOWER) — ₹1,19,832.25 Cr

Indus Towers is a key player in the communication services sector, specializing in telecom infrastructure. With a P/E of 15.43x and a Piotroski score of 7/9, the stock reflects strong financial health. However, PAT growth has declined by -28.06% YoY, signaling potential challenges.

>

Lodha Developers Limited (LODHA) — ₹99,565.1 Cr

Lodha Developers operates in the real estate sector, focusing on residential and commercial projects. With a P/E of 19.71x and revenue growth of 21.02% YoY, the stock shows potential. However, its debt-to-equity ratio of 0.42 and lower ROE of 14.72% may limit upside potential.

>

What This List Doesn't Tell You

This list is based on backward-looking data, such as P/E ratios and growth metrics, which may not fully capture future market conditions. Additionally, sector-specific risks like commodity price fluctuations or regulatory changes can impact these stocks differently.

How to Use This List

This list is a starting point for research, not a buy list. Investors should conduct deeper analysis into each stock’s forensic health, management commentary, and sector-specific trends.

>

Disclaimer

This list is for informational and educational purposes only. It does not constitute investment advice. Consult a SEBI-registered investment advisor before making investment decisions. Data as of the most recent screener_data refresh on InvestSights.

Best Long-Term SIP Stocks India 2026: Growth + Quality

Investing in stocks through SIPs (Systematic Investment Plans) is a proven strategy for building wealth over the long term. For Indian retail investors looking to maximize returns in 2026, this curated list identifies businesses that combine growth, quality, and financial stability. These stocks have been screened for revenue growth, return on capital, low debt, and overall financial health — making them ideal candidates for SIP investing.

How This List Was Generated

>

>

Summary Table

#	Stock	Market Cap (₹ Cr)	Key Metric (ROCE)	P/E (x)	Piotroski	Sector
1	Hindustan Zinc (HINDZINC)	₹2,59,159.94	58.77%	16.02	6/9	Basic Materials
2	Nestlé India (NESTLEIND)	₹2,48,405.45	54.7%	64.73	6/9	Consumer Defensive
3	Eicher Motors (EICHERMOT)	₹2,21,728.01	18.22%	32.75	6/9	Consumer Cyclical
4	Mazagon Dock (MAZDOCK)	₹89,618.93	18.69%	32.25	6/9	Industrials
5	Persistent Systems (PERSISTENT)	₹75,329.28	28.31%	42.35	6/9	Technology
6	NMDC Limited (NMDC)	₹72,128.07	24.25%	9.00	6/9	Basic Materials
7	Dixon Technologies (DIXON)	₹62,985.73	22.8%	35.62	6/9	Technology
8	APL Apollo Tubes (APLAPOLLO)	₹61,818.44	26.34%	44.69	8/9	Basic Materials
9	Oracle Financial Services (OFSS)	₹60,401.62	40.06%	22.18	6/9	Technology
10	Glenmark Pharma (GLENMARK)	₹60,371.22	29.55%	44.17	7/9	Healthcare

Individual Stock Analysis

1. Hindustan Zinc Limited (HINDZINC) — ₹2,59,159.94 Cr

Hindustan Zinc is a leading producer of zinc, lead, and silver in India. It stands out with an impressive ROCE of 58.77% and revenue growth of 18.62% YoY, signaling strong operational efficiency and growth momentum. Its low D/E ratio of 0.39 ensures financial stability.
Key risk: Dependence on commodity prices could impact margins.

>

2. Nestlé India Limited (NESTLEIND) — ₹2,48,405.45 Cr

Nestlé India is a household name in the FMCG sector, offering iconic products like Maggi and Nescafé. With a stellar ROCE of 54.7% and revenue growth of 15.33% YoY, it demonstrates robust profitability and steady growth. Its D/E ratio of 0.08 reflects a conservative financial structure.
Key risk: High valuation with a P/E of 64.73x may limit upside potential.

>

3. Eicher Motors Limited (EICHERMOT) — ₹2,21,728.01 Cr

Eicher Motors is best known for its Royal Enfield motorcycles and commercial vehicles. It boasts revenue growth of 24.95% YoY and a ROCE of 18.22%, highlighting its growth trajectory and operational efficiency. Its D/E ratio of 0.02 reflects minimal leverage.
Key risk: Dependency on discretionary spending in the auto sector.

>

4. Mazagon Dock Shipbuilders Limited (MAZDOCK) — ₹89,618.93 Cr

Mazagon Dock specializes in shipbuilding and defense contracts. It features a ROCE of 18.69% and revenue growth of 13.77% YoY, making it a solid performer in the industrials sector. Its D/E ratio of 0.04 ensures low financial risk.
Key risk: Heavily reliant on government defense budgets.

>

5. Persistent Systems Limited (PERSISTENT) — ₹75,329.28 Cr

Persistent Systems is a leading IT services provider. With revenue growth of 23.53% YoY and a ROCE of 28.31%, it combines growth and operational excellence. Its low D/E ratio of 0.06 reflects prudent financial management.
Key risk: Vulnerable to global IT spending trends.

>

6. NMDC Limited (NMDC) — ₹72,128.07 Cr

NMDC is India's largest iron ore producer. It shines with revenue growth of 34.16% YoY and a ROCE of 24.25%, backed by strong operational performance. Its D/E ratio of 0.18 ensures manageable debt levels.
Key risk: Commodity price volatility could impact earnings.

>

7. Dixon Technologies (India) Limited (DIXON) — ₹62,985.73 Cr

Dixon Technologies is a key player in electronics manufacturing. It boasts revenue growth of 25.77% YoY and a ROCE of 22.8%, showcasing growth potential. Its D/E ratio of 0.21 indicates moderate leverage.
Key risk: Thin margins with an OPM of 3.02%.

>

8. APL Apollo Tubes Limited (APLAPOLLO) — ₹61,818.44 Cr

APL Apollo is India's largest manufacturer of structural steel tubes. It excels with a ROCE of 26.34% and PAT growth of 58.91% YoY, reflecting strong profitability. Its Piotroski score of 8/9 highlights excellent financial health.
Key risk: Competitive pressures in the steel industry.

>

9. Oracle Financial Services Software Limited (OFSS) — ₹60,401.62 Cr

OFSS provides IT solutions for the banking sector. It features a ROCE of 40.06% and revenue growth of 12.05% YoY, indicating steady growth and profitability. Its D/E ratio of 0.004 reflects negligible debt.
Key risk: Dependency on financial sector IT budgets.

>

10. Glenmark Pharmaceuticals Limited (GLENMARK) — ₹60,371.22 Cr

Glenmark is a leading pharmaceutical company. It stands out with revenue growth of 27.08% YoY and a ROCE of 29.55%, showcasing strong growth and profitability. Its Piotroski score of 7/9 highlights solid financial health.
Key risk: Regulatory risks in the healthcare sector.

>

What This List Doesn't Tell You

While this list highlights stocks with strong financial metrics, it is based on backward-looking data. Sector-specific nuances, future market conditions, and management execution are not accounted for. Investors should conduct deeper research before making decisions.

How to Use This List

This curated list is a starting point for research, not a buy recommendation. Use it to identify potential SIP candidates and validate them against your investment goals.

>

Disclaimer

This list is for informational and educational purposes only. It does not constitute investment advice. Consult a SEBI-registered investment advisor before making investment decisions. Data as of the most recent screener refresh on InvestSights.

Disclaimer: This list is for educational and informational purposes only and does not constitute investment advice. Stocks listed here passed a quantitative screen — use the InvestSights stock pages and forensic analysis tools to do your own research before investing. Consult a SEBI-registered advisor before any investment decision.

Tanla Platforms: A P/E of 9.8x in the Tech Sector — Anomaly or Opportunity?

>

Why This Stock Deserves Your Research Attention

Tanla Platforms Limited operates in the software-application space, focusing on cloud communications and messaging solutions. Historically, the company has been a leader in the messaging volume business, but its recent pivot toward a platform and subscription-based revenue model could redefine its growth trajectory. The competitive positioning of Tanla, with a strong promoter holding of 46.17%, suggests a stable ownership structure, though its relatively low institutional interest (FII: 7.6%, DII: 0.28%) may indicate limited visibility among larger investors.

The valuation anomaly is striking: Tanla’s P/E ratio of 9.8x is significantly lower than what is typical for technology companies, which often trade at much higher multiples due to their growth potential. This raises questions about whether the market is undervaluing the stock or pricing in risks related to its business transition. Supporting its financial health, Tanla boasts a robust ROCE of 23.72% and ROE of 20.46%, alongside a manageable debt-to-equity ratio of 0.02. Its Altman Z-score of 5.66 suggests strong financial stability, while a Piotroski score of 6/9 indicates moderate financial strength.

The latest Q1 FY26 concall highlighted a pivotal moment for the company. Management emphasized that Tanla is at an inflection point, shifting from a volume-driven messaging business to a platform and subscription-based model. While this transition could unlock higher-margin revenue streams, the commercial viability of this strategy will be tested in the coming quarters, particularly in Q2 FY26 when key proof points are expected to materialize.

The Numbers That Stand Out

Metric	Value	What It Means
P/E Ratio	9.8x	Significantly lower than sector averages, raising questions about valuation.
ROCE	23.72%	Indicates efficient use of capital to generate returns.
Revenue Growth YoY	9.68%	Moderate growth, but not explosive for a tech company.
PAT Growth YoY	0.37%	Flat profit growth, reflecting potential challenges in scaling margins.
Dividend Yield	3.2%	Attractive for income-focused investors in a tech stock.
Altman Z-Score	5.66	Suggests strong financial stability and low bankruptcy risk.
Current Ratio	2.30	Healthy liquidity position to meet short-term obligations.
EV/EBITDA	5.53x	Indicates a relatively low valuation compared to earnings before interest, taxes, depreciation, and amortization.

The Bull Case

1. Valuation Comfort: With a P/E of 9.8x and an EV/EBITDA of 5.53x, Tanla appears undervalued compared to typical technology sector multiples, which often exceed 20x for P/E and 10x for EV/EBITDA. This could indicate potential upside if the market re-rates the stock.
2. Strong Financial Metrics: The company’s ROCE of 23.72% and ROE of 20.46% suggest efficient capital allocation and profitability, while its low debt-to-equity ratio of 0.02 adds to its financial resilience.
3. Transition to Subscription Model: The pivot to a platform and subscription-driven revenue model could lead to more predictable and higher-margin revenue streams, a trend that has historically been well-received in the tech industry.

The Bear Case

1. Flat Profit Growth: Despite a 9.68% YoY revenue growth, PAT growth was nearly flat at 0.37%, indicating challenges in translating top-line growth into bottom-line performance.
2. Execution Risk in Transition: The shift from a volume-driven business to a subscription model is fraught with execution challenges. The Q2 FY26 results will be critical in assessing the success of this strategy.
3. Limited Institutional Interest: With FII holding at 7.6% and DII at a mere 0.28%, the stock lacks significant backing from institutional investors, which could limit its visibility and trading volumes.

What to Watch Next

1. Q2 FY26 Results: The upcoming quarter will be crucial in evaluating the success of Tanla’s transition to a subscription-based revenue model. Investors should monitor revenue mix and margin trends closely.
2. Institutional Activity: Any increase in FII or DII holdings could signal growing confidence in the stock’s long-term prospects.
3. Dividend Sustainability: With a dividend yield of 3.2%, it will be important to see if the company can maintain or grow its payouts, especially during its business transition.

Explore Further on InvestSights

>

Best Long-Term SIP Stocks India 2026: Growth + Quality

Investing in stocks through SIPs (Systematic Investment Plans) is a proven strategy for building wealth over the long term. For Indian retail investors looking to maximize returns in 2026, this curated list identifies businesses that combine growth, quality, and financial stability. These stocks have been screened for revenue growth, return on capital, low debt, and overall financial health — making them ideal candidates for SIP investing.

How This List Was Generated

>

>

Summary Table

#	Stock	Market Cap (₹ Cr)	Key Metric (ROCE)	P/E (x)	Piotroski	Sector
1	Hindustan Zinc (HINDZINC)	₹2,59,159.94	58.77%	16.02	6/9	Basic Materials
2	Nestlé India (NESTLEIND)	₹2,48,405.45	54.7%	64.73	6/9	Consumer Defensive
3	Eicher Motors (EICHERMOT)	₹2,21,728.01	18.22%	32.75	6/9	Consumer Cyclical
4	Mazagon Dock (MAZDOCK)	₹89,618.93	18.69%	32.25	6/9	Industrials
5	Persistent Systems (PERSISTENT)	₹75,329.28	28.31%	42.35	6/9	Technology
6	NMDC Limited (NMDC)	₹72,128.07	24.25%	9.00	6/9	Basic Materials
7	Dixon Technologies (DIXON)	₹62,985.73	22.8%	35.62	6/9	Technology
8	APL Apollo Tubes (APLAPOLLO)	₹61,818.44	26.34%	44.69	8/9	Basic Materials
9	Oracle Financial Services (OFSS)	₹60,401.62	40.06%	22.18	6/9	Technology
10	Glenmark Pharma (GLENMARK)	₹60,371.22	29.55%	44.17	7/9	Healthcare

Individual Stock Analysis

1. Hindustan Zinc Limited (HINDZINC) — ₹2,59,159.94 Cr

Hindustan Zinc is a leading producer of zinc, lead, and silver in India. It stands out with an impressive ROCE of 58.77% and revenue growth of 18.62% YoY, signaling strong operational efficiency and growth momentum. Its low D/E ratio of 0.39 ensures financial stability.
Key risk: Dependence on commodity prices could impact margins.

>

2. Nestlé India Limited (NESTLEIND) — ₹2,48,405.45 Cr

Nestlé India is a household name in the FMCG sector, offering iconic products like Maggi and Nescafé. With a stellar ROCE of 54.7% and revenue growth of 15.33% YoY, it demonstrates robust profitability and steady growth. Its D/E ratio of 0.08 reflects a conservative financial structure.
Key risk: High valuation with a P/E of 64.73x may limit upside potential.

>

3. Eicher Motors Limited (EICHERMOT) — ₹2,21,728.01 Cr

Eicher Motors is best known for its Royal Enfield motorcycles and commercial vehicles. It boasts revenue growth of 24.95% YoY and a ROCE of 18.22%, highlighting its growth trajectory and operational efficiency. Its D/E ratio of 0.02 reflects minimal leverage.
Key risk: Dependency on discretionary spending in the auto sector.

>

4. Mazagon Dock Shipbuilders Limited (MAZDOCK) — ₹89,618.93 Cr

Mazagon Dock specializes in shipbuilding and defense contracts. It features a ROCE of 18.69% and revenue growth of 13.77% YoY, making it a solid performer in the industrials sector. Its D/E ratio of 0.04 ensures low financial risk.
Key risk: Heavily reliant on government defense budgets.

>

5. Persistent Systems Limited (PERSISTENT) — ₹75,329.28 Cr

Persistent Systems is a leading IT services provider. With revenue growth of 23.53% YoY and a ROCE of 28.31%, it combines growth and operational excellence. Its low D/E ratio of 0.06 reflects prudent financial management.
Key risk: Vulnerable to global IT spending trends.

>

6. NMDC Limited (NMDC) — ₹72,128.07 Cr

NMDC is India's largest iron ore producer. It shines with revenue growth of 34.16% YoY and a ROCE of 24.25%, backed by strong operational performance. Its D/E ratio of 0.18 ensures manageable debt levels.
Key risk: Commodity price volatility could impact earnings.

>

7. Dixon Technologies (India) Limited (DIXON) — ₹62,985.73 Cr

Dixon Technologies is a key player in electronics manufacturing. It boasts revenue growth of 25.77% YoY and a ROCE of 22.8%, showcasing growth potential. Its D/E ratio of 0.21 indicates moderate leverage.
Key risk: Thin margins with an OPM of 3.02%.

>

8. APL Apollo Tubes Limited (APLAPOLLO) — ₹61,818.44 Cr

APL Apollo is India's largest manufacturer of structural steel tubes. It excels with a ROCE of 26.34% and PAT growth of 58.91% YoY, reflecting strong profitability. Its Piotroski score of 8/9 highlights excellent financial health.
Key risk: Competitive pressures in the steel industry.

>

9. Oracle Financial Services Software Limited (OFSS) — ₹60,401.62 Cr

OFSS provides IT solutions for the banking sector. It features a ROCE of 40.06% and revenue growth of 12.05% YoY, indicating steady growth and profitability. Its D/E ratio of 0.004 reflects negligible debt.
Key risk: Dependency on financial sector IT budgets.

>

10. Glenmark Pharmaceuticals Limited (GLENMARK) — ₹60,371.22 Cr

Glenmark is a leading pharmaceutical company. It stands out with revenue growth of 27.08% YoY and a ROCE of 29.55%, showcasing strong growth and profitability. Its Piotroski score of 7/9 highlights solid financial health.
Key risk: Regulatory risks in the healthcare sector.

>

What This List Doesn't Tell You

While this list highlights stocks with strong financial metrics, it is based on backward-looking data. Sector-specific nuances, future market conditions, and management execution are not accounted for. Investors should conduct deeper research before making decisions.

How to Use This List

This curated list is a starting point for research, not a buy recommendation. Use it to identify potential SIP candidates and validate them against your investment goals.

>

Disclaimer

This list is for informational and educational purposes only. It does not constitute investment advice. Consult a SEBI-registered investment advisor before making investment decisions. Data as of the most recent screener refresh on InvestSights.

Disclaimer: This list is for educational and informational purposes only and does not constitute investment advice. Stocks listed here passed a quantitative screen — use the InvestSights stock pages and forensic analysis tools to do your own research before investing. Consult a SEBI-registered advisor before any investment decision.

Gujarat Pipavav Port: P/E of 13.4x — A Valuation Anomaly?

>

Why This Stock Deserves Your Research Attention

Gujarat Pipavav Port Limited (GPPL) operates a strategically located port on India’s western coastline, facilitating container, bulk, and liquid cargo handling. As part of the marine shipping industry, GPPL benefits from India's growing trade volumes and infrastructure development. The company’s competitive position is bolstered by its high operating margin of 50.27% and a robust return on capital employed (ROCE) of 22.34%.

The valuation angle is particularly intriguing. GPPL’s P/E ratio of 13.4x is significantly below the broader sector averages, which often trade at higher multiples due to the capital-intensive nature of the business. This raises the question: does the market undervalue GPPL, or is there a reason for its discounted valuation?

From a forensic perspective, GPPL appears financially sound. Its Piotroski score of 6/9 indicates moderate financial strength, while its Altman Z-score of 8.25 suggests a very low risk of financial distress. With a debt-to-equity ratio of just 0.015, the company is virtually debt-free, further enhancing its financial stability.

The company’s recent performance also warrants attention. Revenue grew 17.28% year-on-year, while profit after tax (PAT) surged 29.8%, indicating operational efficiency and cost management. Investors should evaluate whether these growth rates are sustainable or influenced by one-off factors.

The Numbers That Stand Out

Metric	Value	What It Means
P/E	13.4x	Lower than sector averages, suggesting potential undervaluation.
ROCE	22.34%	Indicates efficient capital deployment and strong profitability.
Dividend Yield	6.74%	Attractive yield, especially for income-focused investors.
Operating Margin	50.27%	Reflects strong operational efficiency in a competitive industry.
Debt-to-Equity	0.015	Virtually debt-free, reducing financial risk.
Altman Z-Score	8.25	Suggests very low risk of financial distress.
Revenue Growth YoY	17.28%	Strong top-line growth, potentially driven by increased trade volumes.
PAT Growth YoY	29.8%	Indicates improved profitability and cost management.

The Bull Case

1. Attractive Valuation: GPPL’s P/E ratio of 13.4x is lower than many of its industry peers, suggesting it may be undervalued relative to its earnings potential.
2. Strong Profitability Metrics: With an operating margin of 50.27% and a net margin of 44.47%, GPPL outperforms many competitors in terms of efficiency and profitability.
3. Financial Stability: A debt-to-equity ratio of 0.015 and an Altman Z-score of 8.25 highlight the company’s strong financial health, reducing concerns about leverage or liquidity risks.

The Bear Case

1. Growth Sustainability: While revenue grew 17.28% and PAT surged 29.8% year-on-year, the 3-year revenue CAGR of 8.1% suggests that growth may not always be as robust.
2. Dividend Sustainability: Although the 6.74% dividend yield is attractive, investors should assess whether the company can maintain this payout given its capital-intensive industry.
3. Sectoral Challenges: The marine shipping industry is cyclical and sensitive to global trade dynamics, which could impact GPPL’s performance during economic downturns.

What to Watch Next

1. Trade Volume Trends: Monitor India’s export and import data, as GPPL’s revenue is closely tied to trade activity.
2. Capex Plans: Any announcements regarding capacity expansion or infrastructure upgrades could impact future growth and capital allocation.
3. Dividend Policy: Keep an eye on the company’s ability to sustain or grow its dividend payout, especially in light of its free cash flow of ₹2,752.9 Cr.

Explore Further on InvestSights

>

Stock of the Day is an educational research series by InvestSights. This article presents data-driven analysis for informational purposes only and does NOT constitute investment advice or a stock recommendation. The stock featured is selected based on interesting financial characteristics worth studying — not based on expected price performance. Always consult a SEBI-registered investment advisor before making investment decisions. Past performance does not guarantee future results.

Warren Buffett's Criteria Applied to Indian Stocks 2026

Which Indian companies pass the Oracle of Omaha's legendary filters — economic moat, pricing power, and financial conservatism?

When Indian retail investors search for Warren Buffett stocks India criteria, they are looking for one thing: businesses with durable competitive advantages that compound wealth quietly over time. Buffett's framework — high returns on capital, fat margins, minimal debt, and steady earnings growth — translates surprisingly well to Indian markets, where a handful of companies have built genuine moats across pharma, consumer goods, defence, and industrials. This list applies exactly those filters to identify 12 Indian-listed companies that score well on Buffett's core principles, giving you a disciplined starting point for deeper research.

>

Summary Table

#	Stock	Market Cap (₹ Cr)	ROCE	OPM	D/E	P/E	Piotroski	Revenue Growth YoY
1	SUNPHARMA	4,24,586	37.64%	52.9%	0.03	37.2x	4/9	8.42%
2	ITC	3,95,547	47.06%	46.09%	0.004	14.6x	5/9	10.88%
3	BEL	3,26,564	33.68%	29.87%	0.003	40.1x	4/9	17.27%
4	BAJAJ-AUTO	2,78,255	32.73%	26.89%	0.26	30.4x	3/9	12.35%
5	EICHERMOT	2,21,728	29.05%	35.53%	0.02	30.8x	5/9	14.01%
6	MOTHERSON	1,41,720	40.86%	18.36%	0.49	23.8x	5/9	15.16%
7	TRENT	1,38,754	57.75%	24.97%	0.41	128.2x	4/9	38.46%
8	CUMMINSIND	1,35,096	37.22%	28.33%	0.004	41.7x	4/9	15.45%
9	POLYCAB	1,29,471	45.17%	20.69%	0.02	38.1x	5/9	24.22%
10	SOLARINDS	1,22,424	46.86%	38.2%	0.22	83.3x	4/9	24.23%
11	POWERINDIA	1,13,218	42.07%	28.3%	0.02	135.9x	2/9	21.91%
12	TATACONSUM	1,12,493	22.25%	33.0%	0.12	76.0x	4/9	15.87%

Individual Stock Analysis

1. Sun Pharmaceutical Industries Limited (SUNPHARMA) — ₹4,24,586 Cr

Sun Pharma is India's largest pharmaceutical company by market capitalisation, with a diversified portfolio spanning specialty, branded generics, and global markets. It makes this Warren Buffett stocks India list primarily because of its exceptional operating profit margin of 52.9% — among the highest in the entire healthcare sector — paired with a near-zero debt-to-equity ratio of 0.03, a textbook Buffett balance sheet. ROCE stands at 37.64%, signalling that capital deployed inside the business generates strong economic returns, and PAT grew 14.12% year-on-year, demonstrating earnings momentum. The key risk here is the Piotroski score of 4/9, which warrants a closer look at working capital trends and earnings quality before drawing conclusions.

>

2. ITC Limited (ITC) — ₹3,95,547 Cr

ITC operates across cigarettes, FMCG, hotels, paperboards, and agribusiness — a diversified conglomerate anchored by an extraordinarily profitable tobacco business. This is arguably the most classically Buffett-compatible name on this list: ROCE of 47.06%, ROE of 49.62%, a D/E of just 0.004, an operating margin of 46.09%, a dividend yield of 3.5%, and PAT growth of 69.84% year-on-year — metrics that collectively scream pricing power and capital efficiency. The Altman Z-Score of 14.26 places it firmly in the financially safe zone, and free cash flow stands at ₹1,534.83 Cr. The one structural caveat is the absence of a disclosed promoter holding, which some investors flag as a governance watch-point.

>

3. Bharat Electronics Limited (BEL) — ₹3,26,564 Cr

BEL is a Navratna defence PSU that manufactures radar systems, electronic warfare equipment, and communication systems primarily for the Indian defence forces — a business protected by one of the widest regulatory moats available in Indian markets. Revenue grew 17.27% year-on-year and PAT expanded 33.55%, reflecting India's accelerating defence indigenisation push under the Make in India programme. ROCE of 33.68% combined with a near-zero D/E of 0.003 and an Altman Z of 11.07 confirm a financially robust balance sheet. The notable flag is negative free cash flow of ₹−42.47 Cr, which reflects heavy capital investment cycles common in defence manufacturing — investors should track order-book conversion carefully.

>

4. Bajaj Auto Limited (BAJAJ-AUTO) — ₹2,78,255 Cr

Bajaj Auto is India's second-largest two-wheeler and three-wheeler manufacturer, with a strong export franchise spanning Africa, Latin America, and Southeast Asia. Its ROCE of 32.73% and OPM of 26.89% reflect genuine pricing power in a competitive segment, and promoter holding is high at 54.75%. However, the Piotroski score of 3/9 is the weakest on this list, and PAT declined 4.98% year-on-year, which departs from Buffett's preference for steady, growing earnings — both are flagged risks that merit scrutiny. Negative FCF of ₹−197.80 Cr also warrants investigation before treating this as a clean Buffett-style compounder.

>

5. Eicher Motors Limited (EICHERMOT) — ₹2,21,728 Cr

Eicher Motors is the parent of Royal Enfield, a motorcycle brand with one of the most loyal customer communities in India — a rare, brand-driven moat that Buffett deeply appreciates. OPM of 35.53% is exceptional for an automobile manufacturer, ROCE clocks in at 29.05%, and D/E is negligible at 0.02, ticking the conservative balance sheet criterion firmly. PAT grew 18.33% year-on-year and revenue grew 14.01%, demonstrating the kind of consistent, mid-teens compounding that characterises durable businesses. The Altman Z of 18.71 is among the highest in this list, offering strong financial distress comfort. The primary risk is the unusually low promoter holding of just 2.2%, which deserves governance scrutiny.

>

6. Samvardhana Motherson International Limited (MOTHERSON) — ₹1,41,720 Cr

Motherson is one of India's largest auto component manufacturers, supplying wiring harnesses, mirrors, and polymer components to global OEMs including BMW, Mercedes-Benz, and Volkswagen. Its ROCE of 40.86% is impressive for a capital-intensive auto ancillary business, and PAT surged 40.01% year-on-year while revenue grew 15.16%, showing strong operating leverage. The Piotroski score of 5/9 is among the better scores in this cohort. The key caution is the D/E of 0.49 — the highest leverage ratio among the clearly qualifying names here — along with an Altman Z of 2.72, which sits closest to the distress threshold on this entire list; both numbers demand careful balance sheet monitoring.

>

7. Trent Limited (TRENT) — ₹1,38,754 Cr

Trent, the Tata Group's retail arm running Westside and Zudio, has emerged as one of India's fastest-growing fashion retailers, with revenue growth of 38.46% year-on-year — the highest on this list by a considerable margin. Its ROCE of 57.75% is the single highest figure across all 12 stocks screened, a remarkable indicator of capital efficiency for a brick-and-mortar retailer. However, its P/E of 128.2x and PAT growth of only 4.03% signal that the market is pricing in a great deal of future perfection, and the near-zero dividend yield of 0.06% means investors receive no income cushion. Buffett-style investors may appreciate the moat but will weigh the valuation premium carefully.

>

8. Cummins India Limited (CUMMINSIND) — ₹1,35,096 Cr

Cummins India manufactures diesel and natural gas engines, generator sets, and related power equipment — a business benefiting from India's infrastructure build-out and backup power demand. The Altman Z of 35.49 is the highest on the entire list by a wide margin, indicating extraordinary financial stability, and the D/E of 0.004 is as close to debt-free as a listed industrial company can get. ROCE of 37.22%, OPM of 28.33%, and PAT growth of 16.24% collectively make this one of the more balanced scorecards in the list when applying Warren Buffett stocks India criteria — strong returns, healthy margins, and minimal leverage. The promoter holding of 51.0% provides governance comfort, though the P/E of 41.7x reflects a premium valuation.

>

9. Polycab India Limited (POLYCAB) — ₹1,29,471 Cr

Polycab is India's leading wires and cables manufacturer, with a growing FMEG (fans, lights, switches) business that gives it a consumer brand alongside its industrial franchise. Revenue grew 24.22% year-on-year, ROCE stands at 45.17%, and the D/E of 0.02 confirms an essentially debt-free balance sheet — three criteria Buffett prizes simultaneously. The Piotroski score of 5/9 is among the better readings in this group, and the promoter holds a high 61.5% stake, signalling skin in the game. At a P/E of 38.1x, the market acknowledges the quality premium, and investors would want to track whether the FMEG segment achieves scale without margin dilution.

>

10. Solar Industries India Limited (SOLARINDS) — ₹1,22,424 Cr

Solar Industries is India's largest manufacturer of industrial and defence explosives — a niche business with high barriers to entry given regulatory licensing requirements and specialised expertise, creating precisely the kind of moat Buffett looks for. OPM of 38.2% and ROCE of 46.86% are exceptional for a manufacturing company, and PAT grew an impressive 44.68% year-on-year alongside revenue growth of 24.23%. Promoter holding is high at 73.15%, and the Altman Z of 24.07 indicates strong financial health. The P/E of 83.3x is elevated, and the D/E of 0.22, while not high in absolute terms, is worth tracking given the capital-intensive nature of expanding explosive manufacturing capacity.

>

11. Hitachi Energy India Limited (POWERINDIA) — ₹1,13,218 Cr

Hitachi Energy India is a critical player in India's power transmission infrastructure, manufacturing transformers, grid automation systems, and high-voltage equipment at a time when India's grid is undergoing massive modernisation. PAT growth of 134.45% year-on-year is the strongest earnings jump on this entire list, and ROCE of 42.07% with a D/E of 0.02 reflects an asset-light and growing business. However, the Piotroski score of 2/9 is the lowest on the list — a significant caution flag that demands forensic scrutiny of earnings quality, receivables, and margin sustainability before drawing any conclusions about durability. The P/E of 135.9x means the valuation leaves no room for execution disappointment.

>

12. Tata Consumer Products Limited (TATACONSUM) — ₹1,12,493 Cr

Tata Consumer Products houses iconic brands including Tata Tea, Tata Salt, and Tetley, giving it a consumer staples moat built on decades of household trust across India and international markets. OPM of 33.0% and revenue growth of 15.87% year-on-year reflect steady top-line momentum consistent with a defensive consumer franchise. The D/E of 0.12 keeps the balance sheet comfortable, and the Altman Z of 7.51 confirms financial stability. The softer metrics — ROCE of 22.25% (the lowest on this list) and ROE of only 6.39% — suggest that capital efficiency has room to improve, possibly reflecting acquisition-driven goodwill on the balance sheet; this is an important nuance for Buffett-criteria investors to examine closely.

>

What This List Doesn't Tell You

All financial metrics used here — ROCE, OPM, D/E, PAT growth — are backward-looking figures based on historical reported data, and past performance does not guarantee future results; a company with a 47% ROCE today can see that erode quickly if competitive dynamics or regulatory conditions shift. Sector-specific nuances matter enormously: a D/E of 0.49 for an auto ancillary with global OEM contracts (Motherson) carries different risk than the same ratio for an unrated NBFC, and operating margins in pharma (Sun Pharma's 52.9%) are structurally incomparable to those in wires and cables (Polycab's 20.69%). Additionally, Piotroski scores of 2–4 across several names on this list are a reminder that meeting Buffett's qualitative criteria does not automatically mean clean accounting signals — forensic analysis is an essential next step.

How to Use This List

This article applies Warren Buffett stocks India criteria as a screening framework, not as a finished investment thesis. Think of these 12 companies as a shortlisted research universe — businesses that cleared quantitative filters and deserve deeper, first-principles analysis. For each name you find interesting, read the last three annual reports, listen to recent concall transcripts to assess management candour, and stress-test the valuation against multiple scenarios before making any capital allocation decision.

>

This list is for informational and educational purposes only. It does not constitute investment advice. Consult a SEBI-registered investment advisor before making investment decisions. Data as of the most recent screener_data refresh on InvestSights.

Disclaimer: This list is for educational and informational purposes only and does not constitute investment advice. Stocks listed here passed a quantitative screen — use the InvestSights stock pages and forensic analysis tools to do your own research before investing. Consult a SEBI-registered advisor before any investment decision.

Adani Ports: 22.9% 3-Year Revenue CAGR Signals Growth Consistency

>

Why This Stock Deserves Your Research Attention

Adani Ports operates a network of ports and terminals across India, handling a significant portion of the country’s cargo movement. The company is strategically positioned in the marine shipping industry, benefiting from India’s growing trade volumes and infrastructure development. With a market capitalization of ₹3,54,026.35 crore and a current market price (CMP) of ₹1,810.1, the stock commands attention for its scale and operational efficiency.

The standout metric for Adani Ports is its 22.93% 3-year revenue CAGR, which underscores its ability to sustain growth over time. This is complemented by a 27.11% year-on-year (YoY) revenue growth and a 15.45% YoY growth in profit after tax (PAT), suggesting that the company is not only expanding its top line but also maintaining profitability. Its operating margin of 44.75% and net margin of 33.06% further highlight its efficiency in converting revenue into profit.

From a forensic perspective, Adani Ports scores 5/9 on the Piotroski F-score, which indicates moderate financial health. The Altman Z-score of 3.45 suggests the company is in a safe zone with a low probability of financial distress. While the Beneish M-score does not flag any earnings manipulation concerns, investors should independently evaluate the company’s debt levels, given its debt-to-equity ratio of 0.66.

The latest concall transcript was unavailable for analysis, but regulatory filings indicate ongoing efforts to expand capacity and optimize operations. Investors should monitor future updates for insights into management’s strategic priorities.

The Numbers That Stand Out

Metric	Value	What It Means
Market Cap	₹3,54,026.35 Cr	Reflects the company’s significant scale.
CMP	₹1,810.1	Current valuation in the market.
3Y Revenue CAGR	22.93%	Consistent growth over three years.
Operating Margin	44.75%	Strong efficiency in operations.
Net Margin	33.06%	High profitability relative to revenue.
ROE	13.32%	Indicates decent returns on equity investments.
D/E Ratio	0.66	Moderate leverage; worth monitoring.
Dividend Yield	0.53%	Modest payout to shareholders.

The Bull Case

1. Consistent Revenue Growth: The 22.93% 3-year revenue CAGR and 27.11% YoY growth demonstrate the company’s ability to scale operations effectively in a growing industry.
2. High Operational Efficiency: Operating and net margins of 44.75% and 33.06%, respectively, indicate strong cost management and profitability.
3. Strategic Positioning: As India’s largest private port operator, Adani Ports is well-positioned to benefit from increasing trade volumes and infrastructure development.

The Bear Case

1. Debt Levels: The debt-to-equity ratio of 0.66 suggests moderate leverage, which could become a concern if interest rates rise or cash flows weaken.
2. Valuation Metrics: The P/E ratio of 22.54x and EV/EBITDA of 14.20x may indicate that the stock is priced at a premium compared to peers in the marine shipping industry.
3. Dividend Yield: At 0.53%, the dividend yield is relatively modest, which may not appeal to income-focused investors.

What to Watch Next

1. Trade and Cargo Volume Trends: Monitor India’s trade activity and cargo volumes, as these directly impact Adani Ports’ revenue growth.
2. Debt Management: Keep an eye on the company’s debt levels and interest coverage ratio (currently 4.52x) to assess financial sustainability.
3. Expansion Plans: Future updates on capacity expansion and operational optimization will be critical for understanding growth potential.

Explore Further on InvestSights

>

Stock of the Day is an educational research series by InvestSights. This article presents data-driven analysis for informational purposes only and does NOT constitute investment advice or a stock recommendation. The stock featured is selected based on interesting financial characteristics worth studying — not based on expected price performance. Always consult a SEBI-registered investment advisor before making investment decisions. Past performance does not guarantee future results.

Sharda Cropchem: A Valuation Anomaly with P/E of 11.5x

>

Why This Stock Deserves Your Research Attention

Sharda Cropchem Limited operates in the agricultural inputs industry, focusing on crop protection chemicals, including fungicides, herbicides, and insecticides. The company has carved out a strong presence in Europe and Latin America, leveraging a lean asset-light model and an extensive portfolio of product registrations. Its competitive edge lies in its ability to scale operations without heavy capital expenditure, supported by a debt-free balance sheet and robust promoter holding of 74.82%.

The stock’s P/E ratio of 11.5x raises questions about whether the market is undervaluing its potential, especially given its high ROE of 21.71% and ROCE of 21.4%. These metrics suggest efficient capital utilization, while its PAT growth of 123.69% YoY underscores its ability to convert revenue into profits effectively. Forensic indicators like an Altman Z-score of 3.63 (indicating financial stability) and a Piotroski score of 5/9 (moderate health) further warrant research attention.

In its latest Q4 FY26 concall, management highlighted record-breaking financial performance driven by strong demand in Europe and LATAM. While the company expressed confidence in sustaining margins, geopolitical risks and competition remain key challenges. Investors should evaluate whether these risks justify the valuation gap or if the stock’s fundamentals suggest a potential re-rating.

The Numbers That Stand Out

Metric	Value	What It Means
P/E Ratio	11.5x	Lower valuation compared to sector norms.
ROE	21.71%	Strong profitability and efficient equity usage.
PAT Growth YoY	123.69%	Exceptional profit growth over the past year.
Altman Z-Score	3.63	Indicates financial stability and low bankruptcy risk.
Revenue Growth YoY	21.94%	Healthy top-line expansion.
Dividend Yield	1.39%	Moderate yield, adds to shareholder returns.
Current Ratio	1.86	Comfortable liquidity position.
FCF	₹6,780.1 Cr	Strong free cash flow generation.

The Bull Case

1. Valuation Anomaly: The P/E ratio of 11.5x is notably lower than many peers in the agricultural inputs sector, suggesting potential undervaluation relative to its growth and profitability metrics.
2. Exceptional Growth: Sharda Cropchem delivered PAT growth of 123.69% YoY and revenue growth of 21.94% YoY, showcasing its ability to scale operations effectively in key international markets.
3. Financial Strength: A debt-free balance sheet (D/E of 0.0), robust free cash flow of ₹6,780.1 Cr, and an Altman Z-score of 3.63 highlight the company’s financial stability and operational efficiency.

The Bear Case

1. Sector Risks: Operating margins of 13.79% and net margins of 12.93%, while healthy, may face pressure from geopolitical uncertainties and competition, as noted in the latest concall.
2. Moderate Forensic Scores: The Piotroski score of 5/9 indicates room for improvement in financial health, particularly in areas like asset efficiency and earnings quality.
3. Valuation Concerns: While the P/E ratio appears attractive, the EV/EBITDA of 7.26x and P/B ratio of 2.5x suggest the stock may not be as undervalued when viewed through other metrics.

What to Watch Next

1. Margin Sustainability: Monitor how Sharda Cropchem navigates geopolitical risks and competition to maintain its operating and net margins in FY27.
2. Growth in Key Markets: Continued performance in Europe and LATAM will be critical for sustaining revenue and profit growth.
3. Sector Valuation Trends: Investors should compare Sharda Cropchem’s valuation metrics with peers to assess whether the P/E anomaly persists or corrects over time.

Explore Further on InvestSights

>

Stock of the Day is an educational research series by InvestSights. This article presents data-driven analysis for informational purposes only and does NOT constitute investment advice or a stock recommendation. The stock featured is selected based on interesting financial characteristics worth studying — not based on expected price performance. Always consult a SEBI-registered investment advisor before making investment decisions. Past performance does not guarantee future results.

Sharda Cropchem: A Valuation Anomaly with P/E of 11.5x

>

Why This Stock Deserves Your Research Attention

Sharda Cropchem Limited operates in the agricultural inputs industry, focusing on crop protection chemicals, including fungicides, herbicides, and insecticides. The company has carved out a strong presence in Europe and Latin America, leveraging a lean asset-light model and an extensive portfolio of product registrations. Its competitive edge lies in its ability to scale operations without heavy capital expenditure, supported by a debt-free balance sheet and robust promoter holding of 74.82%.

The stock’s P/E ratio of 11.5x raises questions about whether the market is undervaluing its potential, especially given its high ROE of 21.71% and ROCE of 21.4%. These metrics suggest efficient capital utilization, while its PAT growth of 123.69% YoY underscores its ability to convert revenue into profits effectively. Forensic indicators like an Altman Z-score of 3.63 (indicating financial stability) and a Piotroski score of 5/9 (moderate health) further warrant research attention.

In its latest Q4 FY26 concall, management highlighted record-breaking financial performance driven by strong demand in Europe and LATAM. While the company expressed confidence in sustaining margins, geopolitical risks and competition remain key challenges. Investors should evaluate whether these risks justify the valuation gap or if the stock’s fundamentals suggest a potential re-rating.

The Numbers That Stand Out

Metric	Value	What It Means
P/E Ratio	11.5x	Lower valuation compared to sector norms.
ROE	21.71%	Strong profitability and efficient equity usage.
PAT Growth YoY	123.69%	Exceptional profit growth over the past year.
Altman Z-Score	3.63	Indicates financial stability and low bankruptcy risk.
Revenue Growth YoY	21.94%	Healthy top-line expansion.
Dividend Yield	1.39%	Moderate yield, adds to shareholder returns.
Current Ratio	1.86	Comfortable liquidity position.
FCF	₹6,780.1 Cr	Strong free cash flow generation.

The Bull Case

1. Valuation Anomaly: The P/E ratio of 11.5x is notably lower than many peers in the agricultural inputs sector, suggesting potential undervaluation relative to its growth and profitability metrics.
2. Exceptional Growth: Sharda Cropchem delivered PAT growth of 123.69% YoY and revenue growth of 21.94% YoY, showcasing its ability to scale operations effectively in key international markets.
3. Financial Strength: A debt-free balance sheet (D/E of 0.0), robust free cash flow of ₹6,780.1 Cr, and an Altman Z-score of 3.63 highlight the company’s financial stability and operational efficiency.

The Bear Case

1. Sector Risks: Operating margins of 13.79% and net margins of 12.93%, while healthy, may face pressure from geopolitical uncertainties and competition, as noted in the latest concall.
2. Moderate Forensic Scores: The Piotroski score of 5/9 indicates room for improvement in financial health, particularly in areas like asset efficiency and earnings quality.
3. Valuation Concerns: While the P/E ratio appears attractive, the EV/EBITDA of 7.26x and P/B ratio of 2.5x suggest the stock may not be as undervalued when viewed through other metrics.

What to Watch Next

1. Margin Sustainability: Monitor how Sharda Cropchem navigates geopolitical risks and competition to maintain its operating and net margins in FY27.
2. Growth in Key Markets: Continued performance in Europe and LATAM will be critical for sustaining revenue and profit growth.
3. Sector Valuation Trends: Investors should compare Sharda Cropchem’s valuation metrics with peers to assess whether the P/E anomaly persists or corrects over time.

Explore Further on InvestSights

>

Stock of the Day is an educational research series by InvestSights. This article presents data-driven analysis for informational purposes only and does NOT constitute investment advice or a stock recommendation. The stock featured is selected based on interesting financial characteristics worth studying — not based on expected price performance. Always consult a SEBI-registered investment advisor before making investment decisions. Past performance does not guarantee future results.

Zydus Lifesciences Limited: A ₹92,794.9 Cr Healthcare Giant with 18.56% Net Margin

>

Why This Stock Deserves Your Research Attention

Zydus Lifesciences Limited operates in the pharmaceutical space, specializing in both generic and specialty drug manufacturing. The company has a strong foothold in the Indian market while also maintaining a significant presence in the US, a key geography for its growth strategy. With promoters holding 75% of the company, Zydus enjoys a stable ownership structure, complemented by institutional interest from DIIs (11.2%) and FIIs (6.95%).

The company's latest quarterly concall highlighted a strategic pivot toward a higher-value, defensible US business mix. This shift comes as the lucrative Revlimid superprofits era winds down, signaling a need for diversification and innovation. The inflection in its 505(b)(2) specialty portfolio could be a critical growth driver, though execution risks remain.

From a forensic perspective, Zydus's Piotroski score of 3/9 suggests room for improvement in financial health, while its Altman Z score of 3.96 indicates a low risk of financial distress. The company’s debt-to-equity ratio of 0.46x and interest coverage ratio of 13.18x reflect manageable leverage, but negative free cash flow (₹-12,026 Cr) raises questions about cash generation.

The Numbers That Stand Out

Metric	Value	What It Means
Market Cap	₹92,794.9 Cr	Reflects Zydus's scale as a major player in the healthcare sector.
P/E	17.39x	Indicates valuation relative to earnings; lower than some peers in healthcare.
Net Margin	18.56%	Highlights profitability; above industry averages for drug manufacturers.
ROE	18.59%	Shows strong shareholder returns on equity invested.
Revenue Growth YoY	16.81%	Demonstrates robust top-line expansion.
D/E	0.46x	Suggests moderate leverage, manageable within industry norms.
Altman Z Score	3.96	Indicates low financial distress risk.
Dividend Yield	1.26%	Provides modest income for shareholders.

The Bull Case

1. Strong Profitability Metrics: Zydus boasts an operating margin of 21.31% and a net margin of 18.56%, underscoring its ability to generate healthy profits from its operations.
2. Consistent Revenue Growth: With a 3-year revenue CAGR of 16.35% and a 5-year CAGR of 13.52%, the company has demonstrated consistent top-line growth, supported by its diversified product portfolio.
3. Strategic US Pivot: The focus on a higher-value, defensible US business mix, as highlighted in the latest concall, could unlock new growth opportunities and reduce reliance on legacy products like Revlimid.

The Bear Case

1. Negative Free Cash Flow: The company reported a free cash flow of ₹-12,026 Cr, raising concerns about its ability to fund growth initiatives without additional leverage.
2. Forensic Red Flags: A Piotroski score of 3/9 suggests weak financial health in areas like profitability, leverage, and efficiency, which may warrant closer scrutiny.
3. Execution Risks in US Strategy: While the pivot to a specialty portfolio in the US is promising, the transition could face challenges, especially as competition intensifies in the generics space.

What to Watch Next

1. US Specialty Portfolio Progress: Monitor updates on the 505(b)(2) portfolio and its contribution to revenue and margins in upcoming quarters.
2. Cash Flow Trends: Keep an eye on free cash flow improvements, as this will be critical for funding growth and maintaining financial stability.
3. Regulatory Developments: Any changes in US FDA approvals or compliance issues could significantly impact Zydus’s growth trajectory.

Explore Further on InvestSights

>

Stock of the Day is an educational research series by InvestSights. This article presents data-driven analysis for informational purposes only and does NOT constitute investment advice or a stock recommendation. The stock featured is selected based on interesting financial characteristics worth studying — not based on expected price performance. Always consult a SEBI-registered investment advisor before making investment decisions. Past performance does not guarantee future results.

I'm building AcharyaJyotish — a serious Vedic astrology platform that brings together the wisdom of Eight Gurus in one chart.

Tagline: “Eight Gurus. One Chart. The Truth in Your Stars.”

After years of studying classical texts and seeing how most modern apps either oversimplify or lack depth, I wanted to create something that respects tradition while being genuinely useful in 2026. The goal is to give accurate, chart-specific insights that serious students, practitioners, and seekers can actually rely on.

Current Features (Website Beta)

• Accurate Sidereal Kundli Generation — Lahiri ayanamsa, full Bhava chart, Nakshatra details, planetary dignities, Ashtavarga, Shadbala, and both North & South Indian chart styles with clean visuals.
• Vimshottari Dasha System — Complete Mahadasha, Antardasha & Pratyantardasha timelines with detailed interpretations for career, relationships, health, wealth, and major life events. Not just dates — actual event mapping.
• Gochar / Transit Analysis — Real-time and future transits with impact on your natal chart. Special focus on Jupiter & Saturn periods + all planets with practical predictions.
• Kundali Milan & Compatibility — Full Ashtakoot scoring (36 points) with breakdown of every Koota, Manglik analysis, and clear dosha explanations. Useful for marriage matching.
• Prashna (Horary) Astrology — Ask a specific question and get a dedicated horary chart analysis with traditional methods.
• Muhurta Selection — Find auspicious timings for marriage, business, travel, griha pravesh, etc., based on panchang + your personal chart.
• Yogas & Doshas Detection — Automatic identification of major yogas (Raja Yoga, Dhana Yoga, Neecha Bhanga, etc.) and doshas (Mangal Dosha, Kaal Sarp, Pitru Dosha, etc.) with strength assessment.
• Personalized Remedies — Practical, prioritized remedies drawn from classics — gemstones (with metal, finger, day & mantra), specific Beej mantras with counts, yantras, rituals, donations, and lifestyle guidance. Not generic lists.
• AI-Enhanced but Shastra-Grounded Interpretations — Readable, contextual insights that blend traditional rules with clear explanations. Designed to help you understand why something is happening in your chart.

MCP (Model Context Protocol) — Coming Soon

We're also building MCP server support (the new open standard for AI agents). This will let tools like Claude, Grok, custom agents, or any MCP-compatible system directly and accurately query the astrology engine for calculations, interpretations, and remedies.

Beta testers will get early access to test and help shape this.

Beta Offer

We're opening limited beta access to both the website and the upcoming MCP.

The first 1,000 beta testers will receive Lifetime Pro subscription completely FREE.

Pro normally unlocks:

• Unlimited chart generations & detailed reports
• Advanced remedy database & prioritization
• Priority feature requests & feedback influence
• Early MCP access + higher usage limits
• PDF exports, timeline views, and future mobile companion features
• Ad-free experience

This is a genuine beta. We're looking for serious feedback on accuracy, missing traditional nuances, UX, and what would actually make this tool indispensable.

If you're a student of Jyotish, a practicing astrologer, someone who wants deep self-insight, or an AI builder interested in MCP + astrology integration — this is for you.

Sign up here: https://acharyajyotish.com/

Once inside, you'll see the beta feedback form. Screenshots and early feedback are very welcome.

Looking forward to your charts and honest thoughts.

Om Shanti.

Tata Coffee: P/E of 14.6x — A Valuation Anomaly in Packaged Foods

>

Why This Stock Deserves Your Research Attention

Tata Coffee Limited, part of the Tata Group, operates in the consumer defensive sector, specializing in coffee production and packaged foods. The company has a diversified product portfolio, including instant coffee, plantation coffee, and tea, catering to both domestic and international markets. Its integration across the value chain and strong brand association with the Tata name provide competitive advantages in a fragmented industry.

The stock's P/E ratio of 14.6x stands out as a potential valuation anomaly when compared to typical multiples in the packaged foods industry. This is particularly intriguing given the company's strong financial performance, including a 77.92% year-on-year growth in profit after tax (PAT) and a return on capital employed (ROCE) of 28.14%. Such metrics often command higher valuation multiples, making the current P/E worth closer scrutiny.

From a forensic perspective, Tata Coffee's Piotroski score of 6/9 indicates moderate financial health, while its Altman Z-score of 3.50 suggests a low risk of financial distress. The company also boasts a manageable debt-to-equity ratio of 0.62 and an interest coverage ratio of 12.64, reflecting a stable balance sheet. However, investors should independently evaluate whether these strengths justify the valuation or if the market is pricing in other risks.

The Numbers That Stand Out

Metric	Value	What It Means
P/E	14.6x	Lower than typical sector multiples, raising questions about valuation.
ROCE	28.14%	Indicates efficient capital allocation and strong profitability.
PAT Growth YoY	77.92%	Exceptional growth in net profit, signaling operational improvements.
Operating Margin	30.28%	Reflects strong cost management and pricing power.
Revenue Growth YoY	21.21%	Highlights robust top-line expansion.
Debt-to-Equity (D/E)	0.62	Shows moderate leverage, manageable for a company of this size.
Dividend Yield	2.01%	Provides steady income for shareholders.
Altman Z-Score	3.50	Suggests low financial distress risk.

The Bull Case

1. Strong Profitability Metrics: Tata Coffee's ROCE of 28.14% and operating margin of 30.28% underscore its ability to generate high returns on capital and maintain cost efficiency. These figures are well above industry averages.
2. Impressive Growth Rates: The company has delivered a 21.21% year-on-year revenue growth and a staggering 77.92% PAT growth, supported by a 3-year revenue CAGR of 13.84%. This suggests sustained operational momentum.
3. Healthy Financial Position: With a debt-to-equity ratio of 0.62 and an interest coverage ratio of 12.64, Tata Coffee appears financially stable. Its Altman Z-score of 3.50 further reinforces the view that the company is not at risk of financial distress.

The Bear Case

1. Low ROE Relative to ROCE: While the ROCE is robust at 28.14%, the return on equity (ROE) is comparatively lower at 14.66%. This gap may indicate inefficiencies in leveraging shareholder equity.
2. Moderate Piotroski Score: A Piotroski score of 6/9, while decent, suggests room for improvement in financial health metrics. Investors should examine areas like asset efficiency and earnings quality.
3. Sector-Specific Risks: The packaged foods industry often faces margin pressures due to fluctuating raw material costs and intense competition. Tata Coffee's net margin of 9.22%, though respectable, could be vulnerable to such headwinds.

What to Watch Next

1. Valuation Trends: Monitor whether the P/E ratio of 14.6x adjusts upward as the market digests the company's growth and profitability metrics, or if it remains subdued due to external factors.
2. Commodity Price Movements: As a coffee producer, Tata Coffee's margins are sensitive to fluctuations in coffee bean prices. Investors should track global commodity trends.
3. Expansion Plans: Any announcements regarding capacity expansion, new product launches, or geographic diversification could serve as catalysts for future growth.

Explore Further on InvestSights

>

Stock of the Day is an educational research series by InvestSights. This article presents data-driven analysis for informational purposes only and does NOT constitute investment advice or a stock recommendation. The stock featured is selected based on interesting financial characteristics worth studying — not based on expected price performance. Always consult a SEBI-registered investment advisor before making investment decisions. Past performance does not guarantee future results.

Sarda Energy: Piotroski 7/9 Signals Strong Fundamentals

>

Why This Stock Deserves Your Research Attention

Sarda Energy & Minerals Limited operates in the steel industry, a key segment of the Basic Materials sector. The company is engaged in producing steel and ferroalloys, with a growing focus on power generation through its Independent Power Producer (IPP) business. Its competitive edge lies in its vertically integrated operations and a diversified revenue stream, which includes a significant contribution from its SKS Power thermal plant.

The company’s Piotroski score of 7/9 suggests strong financial health, as this metric evaluates profitability, leverage, liquidity, and operational efficiency. Complementing this is an Altman Z-score of 4.22, which indicates a low likelihood of financial distress. Investors may find these metrics particularly compelling in a cyclical industry like steel, where financial stability is crucial.

The latest Q1 FY26 concall highlighted a structural earnings transformation. The SKS Power thermal plant, now operating at a 90.21% plant load factor (PLF), contributed ₹627 crore in EBITDA and ₹435 crore in profit after tax (PAT). This marks a significant improvement from the previous year’s PLF of 71.65%, showcasing operational efficiency gains.

The Numbers That Stand Out

Metric	Value	What It Means
Market Cap	₹19,500.78 Cr	Reflects the company's size and investor confidence.
Piotroski Score	7/9	Indicates strong fundamental health across profitability, leverage, and efficiency.
ROE	15.0%	Suggests effective utilization of shareholder equity to generate profits.
Operating Margin	25.42%	Highlights strong operational efficiency in a competitive industry.
Revenue Growth YoY	20.18%	Demonstrates robust top-line expansion.
Debt-to-Equity Ratio	0.357	Indicates a conservative approach to leverage.
Current Ratio	4.50	Reflects strong liquidity, with ample short-term assets to cover liabilities.
Dividend Yield	0.29%	Low yield, suggesting reinvestment of profits for growth.

The Bull Case

1. Strong Financial Health: The Piotroski score of 7/9 and Altman Z-score of 4.22 underscore the company’s robust fundamentals, reducing the risk of financial distress.
2. Earnings Transformation: The SKS Power thermal plant’s improved PLF of 90.21% has significantly boosted EBITDA to ₹627 crore, signaling operational efficiency and a stable revenue stream.
3. Consistent Growth Metrics: With a 20.18% YoY revenue growth and a 33.81% YoY PAT growth, the company demonstrates strong momentum. Its 5-year revenue CAGR of 20.95% further highlights its ability to sustain long-term growth.

The Bear Case

1. Valuation Concerns: A P/E ratio of 16.27x and EV/EBITDA of 11.05x suggest the stock may be priced at a premium compared to some peers in the Basic Materials sector.
2. Low Dividend Yield: At 0.29%, the dividend yield is modest, which may not appeal to income-focused investors seeking regular returns.
3. Sector Cyclicality: Operating in the steel industry, the company remains exposed to global commodity price fluctuations and demand-supply dynamics, which could impact margins.

What to Watch Next

1. SKS Power Plant Performance: Continued high PLF levels and stable contributions to EBITDA will be critical for sustaining earnings growth.
2. Commodity Price Trends: Steel and ferroalloy prices will influence revenue and margin stability, given the cyclical nature of the industry.
3. Debt Management: With a debt-to-equity ratio of 0.357, monitoring any changes in leverage levels will be essential to assess financial prudence.

Explore Further on InvestSights

>

Stock of the Day is an educational research series by InvestSights. This article presents data-driven analysis for informational purposes only and does NOT constitute investment advice or a stock recommendation. The stock featured is selected based on interesting financial characteristics worth studying — not based on expected price performance. Always consult a SEBI-registered investment advisor before making investment decisions. Past performance does not guarantee future results.

>

Why This Stock Deserves Your Research Attention

Nestlé India Limited is the domestic subsidiary of Swiss giant Nestlé S.A., operating across instant noodles (Maggi), chocolates (KitKat, Munch), beverages (Nescafé), and dairy products. Its brand portfolio commands near-institutional trust among Indian consumers, and with promoter holding at 62.76%, the parent's strategic alignment with the Indian business remains structurally intact. The company's competitive moat rests on distribution depth, brand recall, and pricing power — characteristics that have historically justified premium valuations in the consumer defensive space.

The central angle worth studying here is the valuation-versus-growth tension. At a P/E of 67.15x and a P/B of 53.71x, the market is paying an extraordinary premium for earnings quality and consistency. Yet revenue grew only 3.43% year-on-year and PAT grew a mere 0.36% in the latest reported period. The 3-year revenue CAGR of 19.6% and an impressive 5-year revenue CAGR of 51.2% suggest the business has genuine compounding ability over longer horizons — but data suggests that near-term momentum has visibly cooled. An EV/EBITDA of 43.36x further underscores that even on an operational earnings basis, the stock carries significant embedded expectations.

On forensic health, the picture is mixed. The Altman Z-Score of 21.88 is comfortably above the distress threshold (typically below 1.8), signalling negligible financial distress risk — a reassuring data point for a consumer business. However, the Piotroski F-Score of 3/9 is notably low for a company of Nestlé India's perceived quality. The Piotroski framework evaluates profitability, leverage, and operating efficiency signals; a score of 3 suggests that several of these signals are currently not firing positively. Investors should evaluate independently what specific sub-scores are weighing on this metric, as it warrants closer examination. The Beneish M-Score data is unavailable for this period.

The Q4 FY25 concall revealed what may be the single most important structural shift to monitor: Nestlé India's historic growth model has inverted. Traditionally, roughly 9 percentage points of its \~11.2% organic growth CAGR came from volume expansion, with only \~2 percentage points attributable to pricing. Today, that ratio appears reversed — pricing is carrying the load while volume growth is under visible stress. This is a material change in the quality of growth and deserves careful attention. Volume-led growth is generally considered more sustainable and indicative of genuine consumer demand; pricing-led growth, while temporarily supportive of margins, can face elasticity limits.

The Numbers That Stand Out

Metric	Value	What It Means
P/E Ratio	67.15x	Significantly premium; embeds high future growth expectations
PAT Growth YoY	0.36%	Near-flat earnings growth raises questions on near-term valuation support
ROCE	56.84%	Exceptional capital efficiency; core business economics remain strong
ROE	79.99%	Among the highest in Indian FMCG; reflects asset-light, high-margin model
Piotroski F-Score	3/9	Low score; signals several near-term fundamental stress indicators
Altman Z-Score	21.88	Very high; negligible bankruptcy or financial distress risk
Revenue Growth YoY	3.43%	Sharp deceleration from 5-year CAGR of 51.2%
Interest Coverage	58.78x	Extremely comfortable debt serviceability; D/E of only 0.29

The Bull Case

**1. World-class return ratios signal durable competitive advantage.** An ROE of 79.99% and ROCE of 56.84% are not statistical noise — they reflect a business that generates extraordinary returns on the capital deployed. These metrics, sustained over time, are data points that suggest the underlying franchise remains highly profitable even if near-term growth is subdued.

**2. Long-term revenue compounding has been exceptional.** The 5-year revenue CAGR of 51.2% and 3-year revenue CAGR of 19.6% demonstrate that Nestlé India has delivered meaningful top-line growth over extended periods. This historical compounding record is the foundation on which the premium P/E of 67.15x is arguably constructed, and research attention should focus on whether this trajectory can resume.

**3. Negligible financial risk with healthy free cash generation.** With a D/E of just 0.29, interest coverage of 58.78x, and free cash flow of ₹996.54 Cr, the balance sheet is not a concern. The Altman Z-Score of 21.88 corroborates this — data suggests this is a financially resilient business with significant capacity to weather demand-side pressures.

The Bear Case

**1. Valuation leaves almost no margin for error.** At 67.15x P/E and 53.71x P/B, the stock is priced for near-perfection. With PAT growth at only 0.36% YoY, any sustained earnings disappointment could compress multiples significantly. Investors should evaluate independently how much growth is already priced in at the current market cap of ₹2,48,405.45 Cr.

**2. The volume-versus-pricing growth inversion is a structural red flag.** Per the Q4 FY25 concall, pricing is now doing the heavy lifting that volumes historically did. A business growing primarily through price increases rather than volume expansion may be approaching consumer elasticity limits, particularly in a value-conscious market. This inversion deserves to be tracked closely across upcoming quarters.

**3. Current ratio below 1 and a low Piotroski score raise short-term flags.** A current ratio of 0.797 means current liabilities exceed current assets — while common in FMCG businesses with strong supplier terms, it does represent a liquidity characteristic worth monitoring. Combined with a Piotroski F-Score of 3/9, data suggests that multiple near-term fundamental signals are not trending favourably, which investors should evaluate independently before drawing conclusions.

What to Watch Next

1. **Volume growth trajectory in Q1 FY26:** The most critical data point to monitor is whether volume growth recovers in the next quarterly result or whether pricing continues to be the primary growth driver. A sustained volume recovery would materially change the narrative around the growth model inversion flagged in the Q4 FY25 concall.
2. **Operating margin sustainability:** At 21.26%, operating margins are healthy, but raw material cost trends (cocoa, milk solids, wheat) could compress this figure. Investors should track input cost commentary in upcoming management communications for signals on margin direction.
3. **Broader rural consumption recovery:** Nestlé India's volume growth is partly a function of mass-market purchasing power. Any macroeconomic data on rural wage growth, food inflation trends, or FMCG category volume reports from industry trackers would provide independent context for evaluating the demand environment.

Explore Further on InvestSights

>

\*Stock of the Day is an educational research series by InvestSights. This article presents data-driven analysis for informational purposes only and does NOT constitute investment advice or a stock recommendation. The stock featured is selected based on"